NCT01641913View on ClinicalTrials.gov

Intestinal Permeability in Response to Treatment in Eosinophilic Esophagitis Patients

PHASE1CompletedINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

August 31, 2012

Primary Completion Date

January 31, 2014

Study Completion Date

February 28, 2014

Conditions
Eosinophilic Esophagitis
Interventions
OTHER

Absorbable sugars

Lactulose (1,000 mg) and mannitol (200 mg). For the liquid formulation, these sugars will be administered in 250 ml of water. After oral ingestion of the sugars in liquid form, urine will be collected every 30 minutes for the first 2 hours.

Trial Locations (1)

55905

Mayo Clinic in Rochester, Rochester

Sponsors

Lead Sponsor

Mayo Clinic
All Listed Sponsors
lead

Mayo Clinic

OTHER